Union Of India (Uoi) vs Ranbaxy Laboratories Ltd. And Ors.

The Supreme Court upheld the application of the Drugs (Price Control) Order, 1995, and the Essential Commodities Act, 1955, in regulating the pricing of bulk drugs, specifically Pentazocine. The Court clarified that manufacturers must adhere to existing notified prices upon the expiry of exemptions, as stipulated in paragraph 25 of the 1995 Order. The Court affirmed the recovery of overcharged amounts from the pharmaceutical company, emphasizing compliance with statutory pricing regulations under Section 10 of the 1955 Act.